source: Gut Journal
Stuart R. Cairns, John H. Scholefield, Robert J. Steele, Malcolm G. Dunlop, Huw J. W. Thomas, Gareth D. Evans, Jayne A. Eaden, Matthew D. Rutter, Wendy P. Atkin, Brian P. Saunders, Anneke Lucassen, Paul Jenkins, Peter D. Fairclough, Christopher R. J. Woodhouse
The British Society of Gastroenterology (BSG) and the Association of Coloproctology for Great Britain and Ireland (ACPGBI) commissioned this update of the 2002 guidance. The aim, as before, is to provide guidance on the appropriateness, method and frequency of screening for people at moderate and high risk from colorectal cancer. This guidance provides some new recommendations for those with inflammatory bowel disease and for those at moderate risk resulting from a family history of colorectal cancer. In other areas guidance is relatively unchanged, but the recent literature was reviewed and is included where appropriate.
The British Society of Gastroenterology, The Association of Coloproctology for Great Britain and Ireland